Publication: Comparison of the efficacy and safety of using 0.01% versus 0.03% bimatoprost for the treatment of eyebrow hypotrichosis: A randomized, double-blind, split-face, comparative study
Issued Date
2019-01-01
Resource Type
ISSN
14732165
14732130
14732130
Other identifier(s)
2-s2.0-85069651770
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Cosmetic Dermatology. (2019)
Suggested Citation
Poonkiat Suchonwanit, Sarawin Harnchoowong, Nongsak Chanasumon, Tueboon Sriphojanart Comparison of the efficacy and safety of using 0.01% versus 0.03% bimatoprost for the treatment of eyebrow hypotrichosis: A randomized, double-blind, split-face, comparative study. Journal of Cosmetic Dermatology. (2019). doi:10.1111/jocd.13079 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/52100
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Comparison of the efficacy and safety of using 0.01% versus 0.03% bimatoprost for the treatment of eyebrow hypotrichosis: A randomized, double-blind, split-face, comparative study
Other Contributor(s)
Abstract
© 2019 Wiley Periodicals, Inc. Background: Previous studies have proven the efficacy and safety of 0.01% and 0.03% bimatoprost for the treatment of eyebrow hypotrichosis; however, there is no comparison study between both concentrations. Aims: To compare the efficacy and safety between 0.01% and 0.03% bimatoprost for the treatment of eyebrow hypotrichosis. Patients/Methods: This prospective, randomized, double-blind, split-face clinical study was conducted in 30 patients with eyebrow hypotrichosis. Each side of eyebrow of individual patients was randomly assigned for 0.01% and 0.03% bimatoprost, applied on each eyebrow once daily. Eyebrow density, diameter, the Global Eyebrow Assessment scale, 7-point rating scale, and patient satisfaction were evaluated. Side effects were also recorded. Results: Both 0.01% and 0.03% bimatoprost significantly improved eyebrow density and diameter (P <.05), although there were no statistically significant differences in changes in eyebrow density and diameter from baseline between both concentrations (P =.96 and.84, respectively). Additionally, patients significantly preferred 0.03% bimatoprost in terms of clinical improvement and satisfaction (P =.04 and.003, respectively). Conclusions: Both 0.01% and 0.03% bimatoprost are effective and safe for the treatment of eyebrow hypotrichosis. Bimatoprost 0.03% is superior to its 0.01% counterpart, albeit without statistical significance.